Physiologically Based Pharmacokinetic Modeling to Evaluate the Systemic Exposure of Gefitinib in CYP2D6
Ultrarapid Metabolizers and Extensive Metabolizers
2017 ◽
Vol 58
(4)
◽
pp. 485-493
◽
2018 ◽
2019 ◽
Vol 8
(9)
◽
pp. 664-675
◽
2020 ◽
Vol 41
(6)
◽
pp. 248-267
◽
2019 ◽
Vol 59
(6)
◽
pp. 880-889
◽